LONDON--(BUSINESS WIRE)--Due to the increased awareness of the molecular interactions that underpin the normal functioning of the human body, as well as the aberrations that occur with disease, more and more discoveries of the fundamental markers of disease and predisposition to disease are being made on almost a daily basis. This has resulted in the development of more targeted therapies in tandem with complementary diagnostic tests.
New market research report “The UK Diagnostic Testing Market: Forecasts by Market Segment And Supplier Shares by Test” worked out by Venture Planning Group provides a comprehensive overview of the diagnostic testing market in the UK, including sales and market shares of major reagent and instrument suppliers, as well as test volume and sales forecasts for the key market segments – clinical chemistry and immunodiagnostics, infectious disease testing, cancer diagnostics, molecular diagnostics, hematology and flow cytometry, coagulation testing, blood banking.
Report Details:
Title: The UK Diagnostic Testing Market: Forecasts by Market Segment And Supplier Shares by Test
Published: October, 2012
Pages: 58
Price: US$ 3,450.00
Reports on Other Countries Diagnostic Testing Markets by VPG are Also Available:
- The US Diagnostic Testing Market: Forecasts by Market Segment And Supplier Shares by Test
- France Diagnostic Testing Market: Forecasts by Market Segment And Supplier Shares by Test
- Germany Diagnostic Testing Market: Forecasts by Market Segment And Supplier Shares by Test
- Italy Diagnostic Testing Market: Forecasts by Market Segment And Supplier Shares by Test
- Japan Diagnostic Testing Market: Forecasts by Market Segment And Supplier Shares by Test
More new market research reports by VPG can be found at http://marketpublishers.com/members/vpg/info.html